US61945C1036 - Common Stock - After market: 45.29 +0.1 (+0.22%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-02-27 | Citigroup | Maintains | Neutral |
2023-02-24 | Mizuho | Maintains | Buy |
2023-02-23 | UBS | Maintains | Neutral |
2023-02-23 | Credit Suisse | Maintains | Underperform |
2023-02-21 | HSBC | Downgrade | Hold -> Reduce |
2023-01-30 | RBC Capital | Maintains | Sector Perform |
2023-01-24 | UBS | Downgrade | Buy -> Neutral |
2023-01-20 | Citigroup | Downgrade | Buy -> Neutral |
2023-01-19 | Wells Fargo | Initiate | Equal-Weight |
2023-01-13 | Exane BNP Paribas | Downgrade | Neutral -> Underperform |
2023-01-11 | UBS | Maintains | Buy |
2023-01-11 | Morgan Stanley | Maintains | Equal-Weight |
2022-11-22 | Piper Sandler | Maintains | Overweight |
2022-11-10 | RBC Capital | Maintains | Sector Perform |
2022-11-09 | Mizuho | Maintains | Buy |
2022-11-09 | JP Morgan | Maintains | Overweight |
2022-11-09 | Citigroup | Maintains | Buy |
2022-11-01 | Mizuho | Maintains | Buy |
2022-10-03 | RBC Capital | Downgrade | Outperform -> Sector Perform |
2022-08-10 | Barclays | Maintains | Underweight |
2022-08-03 | Citigroup | Upgrade | Neutral -> Buy |
2022-07-29 | Mizuho | Maintains | Buy |
2022-07-14 | Credit Suisse | Initiate | Outperform |
2022-06-01 | Barclays | Initiate | Underweight |
2022-05-31 | Piper Sandler | Maintains | Overweight |
2022-04-29 | Mizuho | Maintains | Buy |
2022-04-21 | RBC Capital | Maintains | Outperform |
2022-03-07 | Piper Sandler | Maintains | Overweight |
2022-03-07 | HSBC | Downgrade | Buy -> Hold |
2022-03-01 | Stifel | Maintains | Hold |
Find the competitors with the best analyst ratings on the USA